A detailed history of Clearstead Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 308 shares of NBIX stock, worth $42,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
308
Previous 748 58.82%
Holding current value
$42,051
Previous $102,000 65.69%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$114.58 - $153.15 $50,415 - $67,386
-440 Reduced 58.82%
308 $35,000
Q2 2024

Aug 09, 2024

BUY
$130.86 - $143.19 $37,295 - $40,809
285 Added 61.56%
748 $102,000
Q1 2024

May 14, 2024

SELL
$130.4 - $143.74 $5,868 - $6,468
-45 Reduced 8.86%
463 $63,000
Q4 2023

Feb 12, 2024

SELL
$106.07 - $132.76 $2,333 - $2,920
-22 Reduced 4.15%
508 $66,000
Q3 2023

Nov 07, 2023

BUY
$94.02 - $117.1 $4,983 - $6,206
53 Added 11.11%
530 $59,000
Q2 2023

Aug 07, 2023

BUY
$89.53 - $104.87 $22,113 - $25,902
247 Added 107.39%
477 $44,000
Q1 2023

May 09, 2023

BUY
$94.11 - $123.02 $21,645 - $28,294
230 New
230 $23,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.